Cargando…
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in the western world. One of the treatments offered for CLL is immunotherapy. These treatments activate various cellular and biochemical mechanisms, using the complement system. Recently it was shown that the complement system...
Autores principales: | Naseraldeen, Naseba, Michelis, Regina, Barhoum, Masad, Chezar, Judith, Tadmor, Tamar, Aviv, Ariel, Shvidel, Lev, Litmanovich, Adi, Shehadeh, Mona, Stemer, Galia, Shaoul, Ety, Braester, Andrei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905172/ https://www.ncbi.nlm.nih.gov/pubmed/33643290 http://dx.doi.org/10.3389/fimmu.2020.603569 |
Ejemplares similares
-
Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia
por: Michelis, Regina, et al.
Publicado: (2022) -
Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway
por: Michelis, Regina, et al.
Publicado: (2020) -
A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity
por: Michelis, Regina, et al.
Publicado: (2019) -
A Puzzling “Switch” in Blood Type Following Blood Transfusion
por: Akria, Luiza, et al.
Publicado: (2017) -
Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
por: Tadmor, Tamar, et al.
Publicado: (2021)